INVO Fertility

INVO Fertility's mission is to address the global infertility crisis by democratizing access to high-quality fertility care. Its core achievement is the development and commercialization of the INVOcell system, a paradigm-shifting technology that enables fertilization and early embryo development within the woman's body, dramatically lowering the cost and complexity of IVF. The company's strategy is dual-pronged: scaling its patient-centric INVO Centers and licensing its technology to established clinics worldwide to drive rapid adoption and market penetration.

The INVOcell system is an intravaginal culture (IVC) device that enables fertilization and early embryo development to occur within the woman's body, serving as a natural incubator and significantly reducing the need for expensive laboratory infrastructure.

INVO competes with traditional, high-cost IVF clinic chains (e.g., Kindbody, CCRM) and lab equipment manufacturers (e.g., Vitrolife). Its primary differentiation is the cost-advantaged, patient-centric INVOcell platform, which circumvents the need for expensive lab incubators, creating a unique niche in the fertility market.